GlassScriptPhysician profile
Janice S Plaxe
NPI 1326144825
$4,631.18
in general payments reported to CMS, 2019-2025
45 companies · $953 in 2025
The $953 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $662 · 2021: $539 · 2022: $461 · 2023: $890 · 2024: $490 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,333.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $703.95 | 2019-2025 | Repatha, Evenity, Krystexxa |
| Janssen Pharmaceuticals, INC | $457.95 | 2019-2022 | |
| Abbvie INC. | $428.26 | 2021-2025 | |
| Abbott Laboratories | $320.30 | 2019-2025 | Aveir, Freestyle Libre 2, Freestyle Libre 3 |
| Astellas Pharma US INC | $282.37 | 2019-2025 | Veozah |
| Amarin Pharma, INC. | $189.41 | 2019-2021 | |
| Kvk-Tech, INC. | $182.26 | 2019-2024 | |
| Cleerly, INC. | $170.90 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Novo Nordisk INC | $166.24 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Heartflow, INC. | $144.76 | 2025 | |
| Glaxosmithkline, LLC. | $129.73 | 2020-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $119.61 | 2023-2025 | Cologuard Collection Kit |
| Almatica Pharma LLC | $90.08 | 2022-2023 | Loreev Xr, Gralise, Sertraline Hcl |
| Lilly USA, LLC | $88.11 | 2019-2024 | Mounjaro, Zepbound |
| Kowa Pharmaceuticals America, INC. | $88.04 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Plaxe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.